---
companies:
- category: unknown
  confidence: medium
  context: attackable target? Today, you'll get to hear A16Z General Partner Vijay
    Ponday in conversation with Eric Topol, who recently rel
  name: General Partner Vijay Ponday
  position: 834
- category: unknown
  confidence: medium
  context: General Partner Vijay Ponday in conversation with Eric Topol, who recently
    released his new book, *Super Agers
  name: Eric Topol
  position: 884
- category: unknown
  confidence: medium
  context: 'Eric Topol, who recently released his new book, *Super Agers: An Evidence-Based
    Approach to Longevity*. Eric i'
  name: Super Agers
  position: 933
- category: unknown
  confidence: medium
  context: 'who recently released his new book, *Super Agers: An Evidence-Based Approach
    to Longevity*. Eric is, among othe'
  name: An Evidence
  position: 946
- category: unknown
  confidence: medium
  context: 'released his new book, *Super Agers: An Evidence-Based Approach to Longevity*.
    Eric is, among other things, the f'
  name: Based Approach
  position: 958
- category: unknown
  confidence: medium
  context: ong other things, the founder and director of the Scripps Research Translational
    Institute. He's also published over 1200 peer-reviewed arti
  name: Scripps Research Translational Institute
  position: 1049
- category: unknown
  confidence: medium
  context: 's really exciting book, *Super-Agers: An Evidence-Based Path to Longevity*.
    And I think it''s a very timely top'
  name: Based Path
  position: 2349
- category: unknown
  confidence: medium
  context: 'uper-Agers: An Evidence-Based Path to Longevity*. And I think it''s a
    very timely topic, and I was curious'
  name: And I
  position: 2375
- category: unknown
  confidence: medium
  context: er been sick. Never been sick? Yeah, her name was Lee Rissol, and her relatives
    had died in their 50s and 60s—
  name: Lee Rissol
  position: 3018
- category: tech
  confidence: high
  context: know, they wanted me to write a prescription for apple mison or order a
    total body MRI. I said, we got t
  name: Apple
  position: 3276
- category: unknown
  confidence: medium
  context: for multiple diseases, which would be one of the Holy Grails of medicine,
    it would be understanding the biolog
  name: Holy Grails
  position: 5021
- category: unknown
  confidence: medium
  context: rge proportion, much more likely to make changes. Now I'm not claiming
    that lifestyle is going to be the
  name: Now I
  position: 11985
- category: unknown
  confidence: medium
  context: with these drugs. This woman in Norway, scientist Lotte Bjerre Knudsen,
    she kept pushing, "We got to try it in obesity,"
  name: Lotte Bjerre Knudsen
  position: 17906
- category: unknown
  confidence: medium
  context: overweight. Yes. Okay. We're going to be doing a Long COVID trial in people
    who are not overweight. The effec
  name: Long COVID
  position: 18861
- category: unknown
  confidence: medium
  context: t back when they stop. Yeah. And that's not good. But I do think that will
    come up with ways to hopefully
  name: But I
  position: 20061
- category: unknown
  confidence: medium
  context: which was initially reported here at Stanford by Tony Wyss-Coray and his
    colleagues, and now validated and r
  name: Tony Wyss
  position: 21362
- category: tech
  confidence: high
  context: g that it's not binary, too, so you can track the gradient. Exactly. And
    that would get particularly scary i
  name: Gradient
  position: 22318
- category: unknown
  confidence: medium
  context: proteins, this is something else that's striking. The Olink and SomaLogic,
    there are between six and 11,000 p
  name: The Olink
  position: 22839
- category: unknown
  confidence: medium
  context: e these organ clocks that are inexpensive to get. The UK Biobank is only
    paying $50 per participant, and they've d
  name: The UK Biobank
  position: 23182
- category: unknown
  confidence: medium
  context: hing $2 trillion. And we live in a time where the United States is an asset
    of debt. There's a great desire to re
  name: United States
  position: 24116
- category: unknown
  confidence: medium
  context: e big insurers to pilot this to make it possible. If May-Maid Oz is listening,
    maybe he'll get interested.
  name: If May
  position: 27089
- category: unknown
  confidence: medium
  context: nsurers to pilot this to make it possible. If May-Maid Oz is listening,
    maybe he'll get interested. I don't
  name: Maid Oz
  position: 27096
- category: tech
  confidence: high
  context: elop one of these three conditions with 20 years' runway. If we can't do
    this for these three diseases, we
  name: Runway
  position: 27753
- category: unknown
  confidence: medium
  context: is for these three diseases, we're not too smart. If AI was before just
    a few years ago, the capabilities
  name: If AI
  position: 27828
- category: unknown
  confidence: medium
  context: 'view in the book. Well, that''s all very rational. So I just want to double-click:
    what needs to change t'
  name: So I
  position: 30927
- category: unknown
  confidence: medium
  context: ge their practice? I don't know. I mean, does the American Hospital Association
    want to have people in their own home so they don
  name: American Hospital Association
  position: 31659
- category: Venture Capital/Tech Investment
  confidence: high
  context: Mentioned as the firm where Vijay Ponday is a General Partner.
  name: A16Z
  source: llm_enhanced
- category: Research Organization/Healthcare Tech
  confidence: high
  context: Eric Topol is the founder and director of this institute.
  name: Scripps Research Translational Institute
  source: llm_enhanced
- category: Biotech/Longevity Tech
  confidence: high
  context: Mentioned as a company receiving remarkable investments focused on reversing
    aging (reprogramming, senolytics).
  name: Altos
  source: llm_enhanced
- category: tech
  confidence: high
  context: Mentioned frequently as a tool for defining high risk, scalable rollout
    of prevention, and improving predictive capabilities.
  name: AI
  source: llm_enhanced
- category: pharma/tech
  confidence: high
  context: Mentioned as one of the developers of the GLP-1 drugs (alongside Novo Nordisk,
    implied by context of Ozempic/Zepbound).
  name: Lily
  source: llm_enhanced
- category: pharma/tech
  confidence: medium
  context: One of the developers of the GLP-1 drugs (Ozempic/Zepbound). The transcript
    mentions 'developers know of an Ornus and later Lily'—'Ornus' is likely a mishearing
    or reference to Novo Nordisk's products/pipeline.
  name: Novo Nordisk (implied by 'Ornus' and context of GLP-1s)
  source: llm_enhanced
- category: organization/research
  confidence: high
  context: Mentioned as the location where the initial reporting on organ clocks (Tony
    Wyss-Coray and colleagues) occurred.
  name: Stanford
  source: llm_enhanced
- category: research/data
  confidence: high
  context: Mentioned as a large-scale project utilizing molecular clocks, having paid
    participants for data collection.
  name: UK Biobank
  source: llm_enhanced
- category: biotech/tech
  confidence: high
  context: Mentioned as a company involved in measuring plasma proteins (molecular
    clocks).
  name: Olink
  source: llm_enhanced
- category: biotech/tech
  confidence: high
  context: Mentioned as a company involved in measuring plasma proteins (molecular
    clocks).
  name: SomaLogic
  source: llm_enhanced
- category: finance/government
  confidence: high
  context: Mentioned as a key government entity whose processes need shifting towards
    prevention, and a potential channel for rolling out new testing packages.
  name: CMS (Centers for Medicare & Medicaid Services)
  source: llm_enhanced
- category: government/health
  confidence: high
  context: Mentioned in comparison to the US system regarding positioning for long-term
    preventative health planning.
  name: NHS (National Health Service)
  source: llm_enhanced
- category: organization/advocacy
  confidence: high
  context: Mentioned rhetorically regarding entities that might resist changes that
    reduce hospital visits.
  name: American Hospital Association
  source: llm_enhanced
date: 2025-05-14 10:00:00 +0000
duration: 42
has_transcript: false
insights:
- actionable: true
  confidence: medium
  extracted: do to change it and improve
  text: we should do to change it and improve.
  type: recommendation
layout: episode
llm_enhanced: true
original_url: https://mgln.ai/e/1344/afp-848985-injected.calisto.simplecastaudio.com/3f86df7b-51c6-4101-88a2-550dba782de8/episodes/ffe8901e-4ff0-409a-aef2-84fc2daf013e/audio/128/default.mp3?aid=rss_feed&awCollectionId=3f86df7b-51c6-4101-88a2-550dba782de8&awEpisodeId=ffe8901e-4ff0-409a-aef2-84fc2daf013e&feed=JGE3yC0V
processing_date: 2025-10-05 17:54:02 +0000
quotes:
- length: 275
  relevance_score: 4
  text: I think when people combine taking the drugs with strength training, and we
    do know there's muscle mass loss just with weight alone, but that looks encouraging,
    even though the companies have been acquiring muscle-making drugs, that may not
    prove to be particularly necessary
  topics: []
- length: 123
  relevance_score: 3
  text: So the first, most important one is AI because you need that to pull all this
    other data we're going to talk about together
  topics: []
- length: 156
  relevance_score: 3
  text: This is perhaps the biggest point so far that we've been discussing because
    in medicine, I've been in it for almost 40 years, we don't do primary prevention
  topics: []
- length: 120
  relevance_score: 3
  text: Well, also the thing about prevention is that I've talked to doctors who very
    boldly assert that prevention doesn't work
  topics: []
- length: 75
  relevance_score: 3
  text: Because prevention's expensive if you have to roll this out with GPs or NPs
  topics: []
- impact_reason: A call to action for systemic change in healthcare, explicitly linking
    massive data availability to the need for a new, personalized standard of care.
  relevance_score: 10
  source: llm_enhanced
  text: There are just billions of data points for each person. There should be a
    reboot, a new standard of care, based on intelligent partitioning of risk.
  topic: Technology/Strategy
- impact_reason: Positions AI as the foundational, necessary layer for integrating
    and making sense of complex multimodal health data.
  relevance_score: 10
  source: llm_enhanced
  text: The first, most important one [dimension of health] is AI because you need
    that to pull all this other data we're going to talk about together.
  topic: Technology/AI
- impact_reason: Signals a major shift where vaccines move from prevention to personalized
    cancer *treatment* (therapeutic vaccines), indicating high-value startup opportunities.
  relevance_score: 10
  source: llm_enhanced
  text: Vaccines now are capable of cures—pancreatic cancer, kidney cancer—with these
    personalized vaccines using the proteins of the person's tumor.
  topic: Startups/Biotech
- impact_reason: Highlights the critical shift from general risk assessment to precise
    temporal prediction of disease onset, enabled by new data.
  relevance_score: 10
  source: llm_enhanced
  text: Now we're saying, we know it's within a couple of years between 77 and 79
    that you're going to have mild cognitive impairment if we don't do these things,
    which includes the lifestyle factors.
  topic: Technology/Predictions
- impact_reason: Provides a concrete example (p-tau217) of a dynamic, modifiable biomarker
    that, when tracked over time with AI, allows for precise intervention timing.
  relevance_score: 10
  source: llm_enhanced
  text: For example, with Alzheimer's, since we were talking about that, you get a
    p-tau217. It's modifiable by lifestyle. You check it again in six months or a
    year. Now you have two data points, and you could say with all the other data
    that's available, when you're going to see 18 years from now, 12 years for you,
    mild cognitive impairment, unless these steps are taken.
  topic: Technology/Biomarkers
- impact_reason: Signals a major inflection point in medical history, driven by recent
    advances, making previously 'fantasy' primary prevention a tangible reality.
  relevance_score: 10
  source: llm_enhanced
  text: We are at a very different point right now. We have a path to prevention,
    primary prevention, not after somebody has one of these diseases. And that is
    what is extraordinary.
  topic: Industry Trend/Inflection Point
- impact_reason: A bold declaration positioning GLP-1s not just as diabetes/obesity
    drugs, but as a paradigm-shifting class with broad systemic benefits.
  relevance_score: 10
  source: llm_enhanced
  text: The GLP-1 drugs, the Ozempic, Zepbound world. It's the most momentous drug
    class in medical history.
  topic: Industry Trend/Pharmaceuticals
- impact_reason: 'Details the multi-layered data approach required for precision health:
    combining established genomic clocks with specific, actionable protein biomarkers.'
  relevance_score: 10
  source: llm_enhanced
  text: We can look at your whole-body aging at the genetic Horvath clock. We can
    also look at specific proteins, like for example, for the brain, p-tau217.
  topic: Data Strategy/Biomarkers
- impact_reason: Provides a staggering metric—a 20-year lead time for Alzheimer's—and
    pairs it with modifiability, creating an urgent call to action for high-risk individuals.
  relevance_score: 10
  source: llm_enhanced
  text: p-tau217... in itself gives us over a 20-year warning about mild cognitive
    impairment. It's modifiable by exercise and lifestyle.
  topic: Biomarker Utility/Actionability
- impact_reason: 'Provides a concrete economic argument for AI/software-based diagnostics:
    they can drastically undercut the cost of traditional lab tests.'
  relevance_score: 10
  source: llm_enhanced
  text: The AI is software, it could be cheap. Whether it's some proteins, a specific
    protein, polygenic risk, these things can be done $20, $50 cheaper than most any
    lab test we do right now.
  topic: Technology/Economics
- impact_reason: Clearly articulates the scalability advantage of AI in healthcare
    delivery, overcoming the bottleneck of human clinician bandwidth.
  relevance_score: 10
  source: llm_enhanced
  text: Prevention's expensive if you have to roll this out with GPs or NPs. But to
    roll out with AI could be very, very scalable.
  topic: Technology/Scalability
- impact_reason: Provides a powerful, quantifiable example of waste and inefficiency
    in current standardized medical practice, setting up the argument for personalized
    risk assessment.
  relevance_score: 10
  source: llm_enhanced
  text: 'We do mass screening for cancer. We treat everyone as the same based on their
    age. That''s the only criterion for screening: age. We only pick up 14% of cancers
    from that mass screening, which costs over hundreds of billions of dollars a year.'
  topic: Healthcare Waste/Efficiency
- impact_reason: 'Pinpoints the primary obstacle to change: entrenched financial incentives
    tied to the existing, inefficient fee-for-service model.'
  relevance_score: 10
  source: llm_enhanced
  text: The problem we have now is the amount of money that's being made by doing
    these screens is humongous. So what is the incentive for the people that are,
    for example, doing the scans and the scopes and all this stuff? Do they want to
    change their practice?
  topic: Business/Incentives
- impact_reason: A strong, counter-intuitive framing of the current healthcare situation,
    shifting the focus from 'reversing aging' to 'preventing age-related disease'
    (cancer, CVD, neurodegenerative).
  relevance_score: 9
  source: llm_enhanced
  text: American healthcare isn't in crisis. We have a path to preventing disease.
    It isn't reversing aging. It's just preventing the age-related morbidities of
    the big three.
  topic: Industry Trends/Strategy
- impact_reason: 'Defines the current technological opportunity: leveraging aging
    metrics data for primary disease prevention, contrasting with the more speculative
    ''reversing aging'' efforts.'
  relevance_score: 9
  source: llm_enhanced
  text: 'The other side of this is we''ve made these big strides in the science of
    aging with all these layers of data that are using the metrics of aging, and why
    don''t we use that to prevent the age-related diseases: cancer, cardiovascular,
    neurodegenerative?'
  topic: Technology/Longevity
- impact_reason: Highlights the specific technological shift from LLMs to LRM (Large
    Reasoning Models) as critical for advanced health data interpretation.
  relevance_score: 9
  source: llm_enhanced
  text: This moment that is so exciting is because we have multimodal AI, not only
    in large language, but large reasoning models now, especially.
  topic: Technology/AI
- impact_reason: Highlights the revolutionary impact of cell therapies (e.g., CAR
    T-cell therapy) as a paradigm shift in treating previously intractable diseases.
  relevance_score: 9
  source: llm_enhanced
  text: Cells that have become a live drug where we can reset the immune system and
    cure autoimmune diseases like we've never done before.
  topic: Technology/Biotech
- impact_reason: Critiques the limitations of static genetic risk scores, setting
    the stage for dynamic, time-sensitive biomarkers.
  relevance_score: 9
  source: llm_enhanced
  text: It's not just like in the year when we had polygenic risk scores. I mean,
    you say, 'Oh, you're at risk for Alzheimer's,' but we don't know when you're age
    56 or 96. So what good is that?
  topic: Technology Critique/Data
- impact_reason: A significant finding challenging the public perception that longevity
    is primarily genetic, redirecting focus to modifiable factors.
  relevance_score: 9
  source: llm_enhanced
  text: The healthy aging story about a genetic underpinning is just not there. We
    study that. It's minimal. I mean, maybe it's 10% of what accounts for healthy
    aging. Most of it is in the lifestyle factors and related matters...
  topic: Longevity/Data Insight
- impact_reason: Describes a specific, powerful application of AI/ML for creating
    personalized, high-confidence predictive health trajectories.
  relevance_score: 9
  source: llm_enhanced
  text: I could also imagine AI coming into this because one of the things AI is very
    good at is to take a set of data and maybe you can mask out the last bit... and
    see if you can predict the last five from the first 25.
  topic: Technology/AI Application
- impact_reason: A strong declaration emphasizing that the convergence of aging science
    and AI is the prerequisite for this new era of personalized prevention.
  relevance_score: 9
  source: llm_enhanced
  text: This was fully dependent on AI models that can just take all this data. If
    we didn't have the science of aging and the AI, we'd be nowhere. We wouldn't be
    talking about this today.
  topic: Technology Convergence
- impact_reason: Highlights the potential for near-perfect, data-driven prognostic
    certainty enabled by advanced AI in health, shifting medicine from reactive to
    deterministic.
  relevance_score: 9
  source: llm_enhanced
  text: Once it gets really good at that, you can take my records and say, 'Hey, look,
    VJ, you don't do anything. This is where you're going to be,' and we have 99%
    confidence on this.
  topic: AI/Personalized Medicine
- impact_reason: A strong statement emphasizing the symbiotic necessity of breakthroughs
    in both biological science (aging) and computational power (AI) to achieve current
    medical progress.
  relevance_score: 9
  source: llm_enhanced
  text: If we didn't have the science of aging and the AI, we'd be nowhere. We wouldn't
    be talking about this today.
  topic: Technology Convergence
- impact_reason: A harsh critique of the current 'sick care' system, framing the lack
    of primary prevention as a systemic failure that new technology must address.
  relevance_score: 9
  source: llm_enhanced
  text: In medicine, I've been in it for almost 40 years, we don't do primary prevention.
    The person has a heart attack and then we get all over it.
  topic: Business/Systemic Critique
- impact_reason: Quantifies the massive potential return on investment for basic lifestyle
    interventions, creating a compelling value proposition.
  relevance_score: 9
  source: llm_enhanced
  text: We're talking about just with that [lifestyle changes], seven years more of
    health span, free of the major three diseases. Seven years, who wouldn't take
    seven years?
  topic: Business Case/ROI
- impact_reason: 'Defines the strategic pivot enabled by AI: moving from generalized
    advice to hyper-focused, personalized intervention based on risk stratification.'
  relevance_score: 9
  source: llm_enhanced
  text: Once we can define high risk, which is one of the things we turn to with AI,
    that changes everything because then you focus on that.
  topic: AI Strategy/Focus
- impact_reason: Predicts massive, rapid adoption of oral formulations of these drugs,
    fundamentally changing population health management.
  relevance_score: 9
  source: llm_enhanced
  text: It wouldn't be surprising to me that now with pills that are remarkably effective
    to substitute for injections... that a large proportion of the population would
    be taking one of these drugs or even their successors.
  topic: Future Prediction/Adoption
- impact_reason: Illustrates the concept of 'unintended positive externalities' in
    drug development—a single breakthrough yielding massive, unforeseen benefits across
    multiple domains (addiction, brain circuitry).
  relevance_score: 9
  source: llm_enhanced
  text: The ability to crack obesity. Yes. We would have been happy just to do that.
    But all the other things that are coming from it, who would have thought that
    you could treat, prevent addiction?
  topic: Innovation/Unexpected Value
- impact_reason: Connects preventative health directly to massive macroeconomic benefits,
    framing it as an economic imperative, not just a medical one.
  relevance_score: 9
  source: llm_enhanced
  text: If we can make a huge dent, there's nothing more economically favorable for
    us at the public population health level if we can achieve this.
  topic: Economic Impact/Policy
- impact_reason: Highlights the maturation and validation of 'organ clocks' (biological
    aging metrics) from novel research to established, replicable science.
  relevance_score: 9
  source: llm_enhanced
  text: The ability to look at the organ clocks, which was initially reported here
    at Stanford... and now validated and replicated by multiple groups.
  topic: Biotech/Validation
- impact_reason: 'Directly addresses the core business and policy challenge: aligning
    incentives across payers (CMS, insurers) to reward prevention over treatment.'
  relevance_score: 9
  source: llm_enhanced
  text: How do we shift the system, whether we're talking about CMS or we're talking
    about insurers or providers? How do we shift the sick care system to be thinking
    about preventative and chronic?
  topic: Policy/Business Model Shift
- impact_reason: Highlights the fundamental structural challenge in the current US
    healthcare system—the inertia towards treating sickness rather than preventing
    it.
  relevance_score: 9
  source: llm_enhanced
  text: How do we shift the sick care system to be thinking about preventative and
    chronic?
  topic: Industry Trends/Strategy
- impact_reason: Identifies a critical market failure in the US insurance model (short-term
    incentives) that actively hinders long-term preventative investment, a key barrier
    for health tech solutions.
  relevance_score: 9
  source: llm_enhanced
  text: We have a barrier here because although many and senders, people could change
    their insurance companies at any time. So the insurance company doesn't have a
    long view.
  topic: Business/Policy
- impact_reason: Addresses the crucial issue of equity and access in advanced health
    tech. Solutions must be universally distributed to succeed systemically.
  relevance_score: 9
  source: llm_enhanced
  text: As the people who need this the most are currently the least likely to get
    it to access. And so this is another issue, which if this only is for the affluent,
    if we don't take care of everyone, we're not going to achieve that goal.
  topic: Ethics/Business Strategy
- impact_reason: 'Crucial insight for tech developers: preventative health can demonstrate
    ROI quickly using measurable biomarkers (surrogate endpoints), accelerating adoption.'
  relevance_score: 9
  source: llm_enhanced
  text: We don't have to wait 10 years to see the benefit. If we see the clocks all
    changing in the right direction, we have an intermediate surrogate endpoint.
  topic: Startups/Product Validation
- impact_reason: 'Reinforces the network effect and data flywheel inherent in AI solutions:
    scale improves the product, which drives further scale.'
  relevance_score: 9
  source: llm_enhanced
  text: As we do this and we do this at scale, it just keeps getting better.
  topic: Technology/AI Strategy
- impact_reason: A direct call to action for the medical community to overhaul malpractice
    and standard-of-care guidelines using modern risk assessment tools.
  relevance_score: 9
  source: llm_enhanced
  text: There should be a reboot, a new standard of care based on intelligent partitioning
    of risk.
  topic: Policy/Standard of Care
- impact_reason: Suggests that true disruption comes not from a single technology,
    but the synergy between new risk assessment science (genomics, biomarkers) and
    AI processing power.
  relevance_score: 9
  source: llm_enhanced
  text: What's different now is that AI or is it the confluence of all these things?
  topic: Technology Trends/Confluence
- impact_reason: 'Defines the unique value proposition of AI in this context: handling
    data complexity that is fundamentally impossible for human clinicians to process.'
  relevance_score: 9
  source: llm_enhanced
  text: The AI part of it is this is beyond human capability. There are just billions
    of data points for each person.
  topic: Technology/AI Capability
- impact_reason: Provides a specific, cutting-edge example of AI enhancing imaging
    diagnostics beyond traditional structural metrics (i.e., detecting subclinical
    disease).
  relevance_score: 9
  source: llm_enhanced
  text: We can use AI to tell if there's inflammation in the heart arteries, even
    without a significant narrowing.
  topic: Technology/Medical Imaging
- impact_reason: Core economic argument for preventative health investment, highly
    relevant for insurance, payers, and health tech business models.
  relevance_score: 8
  source: llm_enhanced
  text: If we can keep people healthier, healthier people would be much less expensive.
  topic: Business/Strategy
- impact_reason: Provides concrete, high-impact statistics on the preventability of
    the 'big three' diseases via lifestyle, emphasizing the immediate ROI of behavioral
    change.
  relevance_score: 8
  source: llm_enhanced
  text: Cardiovascular, 80 and 90 percent from lifestyle and related factors, modifiable
    factors like your LDL cholesterol, that kind of thing. And cancer and neurodegenerative,
    just from what we know today with lifestyle factors, we're about half that can
    be prevented.
  topic: Industry Trends/Data
- impact_reason: Illustrates the democratization and expansion of 'omics' data beyond
    genomics to proteomics and metabolomics, driven by cost reduction.
  relevance_score: 8
  source: llm_enhanced
  text: The omics, it includes not just gene sequence or arrays, but it has all the
    proteins, all the proteomic panels that we can get, which we never could get before,
    inexpensively.
  topic: Technology/Data
- impact_reason: A powerful metaphor describing the newfound precision in modulating
    the immune system, suggesting continuous improvement through better measurement.
  relevance_score: 8
  source: llm_enhanced
  text: The bigger lesson is we have learned how to control our immune system like
    a rheostat, and we're going to keep getting better and better as we measure our
    immune zone.
  topic: Technology/Biotech
- impact_reason: A bold prediction about the future of oncology, emphasizing that
    prevention via immune modulation will become standard.
  relevance_score: 8
  source: llm_enhanced
  text: It's hard to imagine that in the future, we're going to lose people with cancer
    because of being able to bring your immune system to the highest level when we
    need it. But more importantly, preventing the cancer, we can do that now.
  topic: Predictions/Industry Trends
- impact_reason: Expands the definition of 'lifestyle' intervention for tech and health
    professionals, pointing toward environmental monitoring and mitigation as a new
    health frontier.
  relevance_score: 8
  source: llm_enhanced
  text: 'I call it lifestyle plus. It''s a lot bigger than diet, sleep, and exercise.
    It''s involving all the environmental burdens: air pollution, the plastics, microplastics,
    nanoplastics, and forever chemicals.'
  topic: Industry Trends/Strategy
- impact_reason: 'Provides a key behavioral insight for health tech product design:
    personalization of risk data drives adherence.'
  relevance_score: 8
  source: llm_enhanced
  text: So we know when people get data that's specific to them, a large proportion,
    much more likely to make changes.
  topic: Business/Behavioral Science
- impact_reason: 'Illustrates the ultimate value proposition of predictive health
    modeling: high-confidence, personalized consequence visualization.'
  relevance_score: 8
  source: llm_enhanced
  text: And once it gets really good at that, you can take my records and say, 'Hey,
    look, VJ, you don't do anything. This is where you're going to be,' and we have
    99% confidence on this. That would be pretty chill.
  topic: Technology/Impact
- impact_reason: Presents empirical evidence (the Welderly study) supporting the low
    genetic contribution to extreme healthspan.
  relevance_score: 8
  source: llm_enhanced
  text: We had done a big study we called the Welderly, where we basically found very
    little in the genomes of people who had gone to the age of 87 on average with
    never having had an age-related disease.
  topic: Data Insight/Longevity
- impact_reason: Defines a critical strategic metric in longevity and preventative
    health, shifting focus from mere survival to quality of life.
  relevance_score: 8
  source: llm_enhanced
  text: It's important for people unfamiliar with the term of health span. That's
    basically not just lifespan, but how long you can be healthy.
  topic: Strategy/Health Metrics
- impact_reason: 'Crucial insight for tech companies entering health: success requires
    addressing cultural adoption alongside scientific efficacy.'
  relevance_score: 8
  source: llm_enhanced
  text: I think some of this or much of this has to be as much cultural as medical.
  topic: Business Strategy/Adoption
- impact_reason: Provides a specific, actionable lifestyle lever (deep sleep) linked
    directly to reducing mortality across the 'big three' disease categories.
  relevance_score: 8
  source: llm_enhanced
  text: With sleep, when you promote your own deep sleep... then you see much less
    dementia, Alzheimer's, even less cardiovascular and cancer-related illnesses,
    cases, and mortality.
  topic: Actionable Health Insights
- impact_reason: A sharp critique of current diagnostic methods (like TBMRI) in favor
    of superior, less invasive, and potentially earlier detection technologies (MCDTs).
  relevance_score: 8
  source: llm_enhanced
  text: Why people would get a total body MRI when you could find microscopic cancer,
    not a mass on an MRI, which may or may not be cancer?
  topic: Technology Comparison/Diagnostics
- impact_reason: Identifies the convergence of three major biological research areas
    (gut-brain, immune, aging) as the engine for future medical breakthroughs.
  relevance_score: 8
  source: llm_enhanced
  text: Some of the secrets of the gut-brain axis, which is tied into the immune system,
    and it's tied into the science of aging, this is what's given us this new found
    potential to change.
  topic: Scientific Foundation
- impact_reason: 'Provides a crucial strategic argument for pharmaceutical intervention:
    drugs can serve as a necessary ''on-ramp'' to enable sustainable lifestyle changes
    for the most challenging populations.'
  relevance_score: 8
  source: llm_enhanced
  text: Another knock on lifestyle is if you're extremely obese, telling someone to
    exercise, it's a hard road to just get started. Absolutely. And so this could
    jumpstart a better lifestyle that could get locked in.
  topic: Business Strategy/Adoption Barrier
- impact_reason: 'Establishes the critical threshold for intervention: risk stratification
    must precede action, emphasizing precision over mass screening for costly interventions.'
  relevance_score: 8
  source: llm_enhanced
  text: I don't recommend any of these things that we're talking about until you know
    you have an increased risk. But once you do, then you can say, 'Hmm, I can do
    something about it and change the course of what otherwise would be that person's
    natural history.'
  topic: Strategy/Intervention Threshold
- impact_reason: Suggests that technological capability alone isn't enough; systemic
    change requires forceful policy intervention to mandate preventative focus across
    all payers.
  relevance_score: 8
  source: llm_enhanced
  text: If we could make prevention, now that it is emerging as a reality, the priority,
    and say every insurer... then we have to make some pretty drastic policy changes.
  topic: Policy/Technology Adoption
- impact_reason: Identifies CMS (Medicare/Medicaid) as the ultimate target for scaling
    validated preventative health packages due to their massive reach.
  relevance_score: 8
  source: llm_enhanced
  text: We have the metrics again to get a short, quick assessment already making
    a difference. If we did that through CMS, that would be phenomenal.
  topic: Business/Market Strategy
- impact_reason: Sets an extremely high bar for the capability of modern predictive
    AI in health, framing failure to utilize it as intellectual negligence.
  relevance_score: 8
  source: llm_enhanced
  text: The ability to predict pinpoint temporarily when a person is likely to develop
    one of these three conditions with 20 years' runway. If we can't do this for these
    three diseases, we're not too smart.
  topic: Technology/Prediction
- impact_reason: 'The ultimate advice for convincing entrenched professionals: scientific
    evidence trumps tradition or anecdote.'
  relevance_score: 8
  source: llm_enhanced
  text: To me, it's all about compelling data.
  topic: Strategy/Adoption
- impact_reason: A sharp critique of current regulatory approval standards, suggesting
    that measurable (even if imperfect) biomarkers drive adoption more than clinical
    outcomes.
  relevance_score: 8
  source: llm_enhanced
  text: The Alzheimer's drugs, which don't really work, and they're very risky. But
    the reason they were bought into by the FDA ultimately was because the amyloid
    came out on the scans, right?
  topic: Policy/FDA Critique
- impact_reason: 'A classic business insight applied to healthcare disruption: anticipate
    and manage resistance from incumbents whose revenue streams are threatened.'
  relevance_score: 8
  source: llm_enhanced
  text: In any change, there's always new winners and losers, and the potential new
    losers will fight the change.
  topic: Business Strategy/Disruption
- impact_reason: Reiterates that the barrier to adopting cost-saving, preventative
    technology is political/economic will, not technical feasibility.
  relevance_score: 8
  source: llm_enhanced
  text: We have to have the will. The problem we have now is the amount of money that's
    being made by doing these screens is humongous.
  topic: Business/Policy
- impact_reason: Emphasizes the necessity of high-density, evidence-based data to
    drive actionable lifestyle changes, moving beyond vague advice.
  relevance_score: 7
  source: llm_enhanced
  text: I go into perhaps great pains, high density, to cite all the studies that
    link, like for example, when you have really good sleep health and deep sleep,
    what does that do to slow your brain aging?
  topic: Data/Actionable Advice
- impact_reason: Provides stark, quantifiable data on the burden of chronic disease
    in the general aging population, justifying the need for intervention.
  relevance_score: 7
  source: llm_enhanced
  text: For comparison, according to Eric's book, among those 65 plus, 80 percent
    have two or more chronic diseases, and 23 percent have three or more...
  topic: Industry Trends/Statistics
- impact_reason: Illustrates the gap between patient demand (often driven by hype)
    and evidence-based medical reality, a key challenge for health tech adoption.
  relevance_score: 7
  source: llm_enhanced
  text: I had patients coming to me, you know, they wanted me to write a prescription
    for apple mison or order a total body MRI. I said, we got to get the story straight.
  topic: Business/Hype Cycle
- impact_reason: Uses the historical success of tobacco control as proof that large-scale
    behavioral/lifestyle changes are achievable, countering claims that prevention
    'doesn't work.'
  relevance_score: 7
  source: llm_enhanced
  text: I was like, how about smoking? That's a part of time. We had this huge incidence
    of lung cancer, which has just disappeared now because we don't smoke in restaurants
    or airplanes and so on.
  topic: Strategy/Behavioral Change
- impact_reason: Highlights the immediate utility of existing genetic data (PRS) as
    a foundational layer for preventative cancer care.
  relevance_score: 7
  source: llm_enhanced
  text: I think we can make a huge impact in cancer because we have just simple polygenic
    risk scores for all the common cancers.
  topic: Genomics/Cancer Prevention
- impact_reason: Confirms the practical, real-world impact of the 'jumpstart' theory
    mentioned previously, validating a combined approach.
  relevance_score: 7
  source: llm_enhanced
  text: I've seen it in many patients, just what you said. Couldn't get them to really
    increase their activity, but when they were thinner, everything changed.
  topic: Clinical Anecdote/Validation
- impact_reason: Challenges the simple, linear model of aging, suggesting non-linear
    phases that require different interventions at different life stages.
  relevance_score: 7
  source: llm_enhanced
  text: The fact that there are three bursts of aging during our life is not just
    a linear story...
  topic: Scientific Insight/Aging Model
- impact_reason: Acknowledges the reality of organizational inertia and skepticism
    that innovators face when introducing disruptive change.
  relevance_score: 7
  source: llm_enhanced
  text: There are a lot of enemies of the future... people could be skeptical... they
    have a certain belief that this isn't going to work for whatever reason.
  topic: Business/Change Management
- impact_reason: A provocative statement arguing that current standardized care ignores
    measurable individual risk profiles, implying a moral/intellectual failing.
  relevance_score: 7
  source: llm_enhanced
  text: We don't treat people as human beings with particular aspects that we can
    define today. And what do you think that is? We're ingrained in stupidity.
  topic: Philosophy/Personalization
- impact_reason: Creates a sense of urgency and a 'now or never' moment regarding
    the current technological window for healthcare transformation.
  relevance_score: 7
  source: llm_enhanced
  text: We have a new way forward if we are willing to get it validated. And I hope
    we'll seize this opportunity because we may never get another one like this for
    a long time.
  topic: Strategy/Urgency
- impact_reason: A highly provocative summary statement emphasizing the intellectual
    failure of ignoring readily available, powerful technological solutions.
  relevance_score: 7
  source: llm_enhanced
  text: If we don't do this, we're just stupid.
  topic: Philosophy/Strategy
source: Unknown Source
summary: "## Comprehensive Summary: Super-Agers, Preventative Health, and the AI-Driven\
  \ Healthcare Reboot\n\nThis A16Z podcast episode features General Partner **Vijay\
  \ Ponday** in conversation with **Dr. Eric Topol**, founder/director of the Scripps\
  \ Research Translational Institute and author of the new book, *Super Agers: An\
  \ Evidence-Based Approach to Longevity*. The central narrative arc revolves around\
  \ shifting the focus of American healthcare from treating late-stage chronic disease\
  \ (\"sick care\") to leveraging modern data science and biology to achieve **primary\
  \ prevention** and extend **health span**—not just lifespan.\n\n---\n\n### Key Takeaways\
  \ for Technology Professionals\n\n1.  **The Preventative Imperative:** The core\
  \ argument is that American healthcare is not in crisis due to a lack of longevity,\
  \ but a lack of **health span**. The goal is preventing the \"big three\" age-related\
  \ morbidities (cancer, cardiovascular disease, and neurodegenerative diseases),\
  \ which are heavily exacerbated by age. This preventative approach is economically\
  \ essential, as healthier people are significantly less expensive.\n2.  **AI as\
  \ the Unifying Framework:** **Multimodal AI** (including large reasoning models)\
  \ is identified as the crucial technology required to synthesize the massive, complex\
  \ datasets now available. AI is necessary to partition risk intelligently, personalize\
  \ interventions, and predict the timing of disease onset (e.g., predicting Mild\
  \ Cognitive Impairment (MCI) years in advance using biomarkers like p-tau217).\n\
  3.  **The Five Dimensions of Health:** Dr. Topol outlines a framework for understanding\
  \ modern health data, all requiring AI integration:\n    *   **AI/Reasoning Models:**\
  \ To integrate all other data layers.\n    *   **Omics:** Genomics, proteomics (inexpensive\
  \ panels), metabolomics, and the microbiome.\n    *   **Cells as Drugs:** Revolutionary\
  \ cures for autoimmune diseases (e.g., lupus, MS) via B-cell depletion and immune\
  \ system resetting.\n    *   **Immune System Modulation:** Vaccines (including personalized\
  \ cancer vaccines) and advanced drugs (like ADCs) are fundamentally changing cancer\
  \ treatment and prevention potential.\n    *   **Lifestyle Plus:** Moving beyond\
  \ basic diet/exercise to include environmental burdens (plastics, pollution) and\
  \ specific, evidence-backed rituals (like deep sleep regularity).\n\n### Major Topics\
  \ and Technical Concepts\n\n*   **The Welderly Study:** Topol highlighted research\
  \ on \"super-agers\" (people 80+ with no chronic illness), finding minimal genetic\
  \ underpinning (suggesting lifestyle/agency is dominant, perhaps only 10% genetic).\n\
  *   **Organ Clocks:** The ability to measure the biological age of specific organs\
  \ (brain, heart, immune system) using molecular markers, often validated through\
  \ large cohorts like the **UK Biobank**. This allows for pinpointing which organ\
  \ is aging fastest relative to chronological age.\n*   **Biomarkers and Timing:**\
  \ The power of specific, modifiable biomarkers, such as **p-tau217** for Alzheimer's,\
  \ which offers a 20-year warning window and is highly responsive to lifestyle changes.\n\
  *   **GLP-1 Drugs (Ozempic/Wegovy):** Described as the \"most momentous drug class\
  \ in medical history.\" Their impact extends far beyond diabetes/obesity to potentially\
  \ reducing cancer, heart disease, and neurodegenerative risks. They are also showing\
  \ surprising effects on brain circuitry, impacting addiction and gambling behaviors.\n\
  \n### Business Implications and Strategic Insights\n\n*   **Systemic Shift Required:**\
  \ The current \"sick care\" system, driven by short-term insurance views, fails\
  \ to incentivize primary prevention. A systemic reboot is needed, likely involving\
  \ CMS and insurers adopting longer-term, preventative reimbursement models.\n* \
  \  **Data Specificity Drives Action:** Personalization is key to changing behavior.\
  \ Providing individuals with highly specific, data-driven predictions (e.g., \"\
  If you continue this, you will have MCI at age X\") is far more effective than vague\
  \ advice, mirroring the success seen when smokers received personalized risk data.\n\
  *   **Economic Win-Win:** Preventing just seven years of morbidity from the big\
  \ three diseases offers massive potential savings for public health systems (Medicare/Medicaid,\
  \ approaching $2 trillion annually).\n\n### Challenges and Recommendations\n\n*\
  \   **Challenge:** The difficulty of shifting physician mindset away from reactive\
  \ treatment toward primary prevention, despite historical successes like tobacco\
  \ control.\n*   **Challenge:** The rebound effect of GLP-1 drugs, where weight is\
  \ regained upon cessation, suggesting a need for sustained intervention or successor\
  \ drugs that require less long-term commitment.\n*   **Recommendation:** Individuals\
  \ should focus on **Lifestyle Plus** factors, supported by data showing that optimizing\
  \ sleep, nutrition, and environmental exposure can yield tangible results (e.g.,\
  \ seven extra healthy years).\n*   **Recommendation:** For high-risk individuals,\
  \ leveraging AI-integrated molecular clocks and biomarkers allows for targeted,\
  \ evidence-based intervention *before* symptoms manifest."
tags:
- artificial-intelligence
- ai-infrastructure
- generative-ai
- startup
- investment
- apple
title: What Super Agers Reveal About Preventing Disease
topics:
- keywords:
  - ai
  - machine learning
  - deep learning
  - neural networks
  - llm
  - large language model
  mentions: 59
  prominence: 1.0
  topic: artificial intelligence
- keywords:
  - gpu
  - tensor
  - training
  - inference
  - model deployment
  - vector database
  mentions: 2
  prominence: 0.2
  topic: ai infrastructure
- keywords:
  - generative ai
  - genai
  - chatgpt
  - gpt
  - claude
  - text generation
  - image generation
  mentions: 1
  prominence: 0.1
  topic: generative ai
- keywords:
  - startup
  - entrepreneur
  - founder
  - venture
  mentions: 1
  prominence: 0.1
  topic: startup
- keywords:
  - investment
  - funding
  - valuation
  - ipo
  - acquisition
  mentions: 1
  prominence: 0.1
  topic: investment
---

<!-- Episode automatically generated from analysis data -->
<!-- Processing completed: 2025-10-05 17:54:02 UTC -->
